pharma news

News

AHA: Cash for drug adherence study has disappointing result

People with hypertension were twice as likely to take medicine regularly when offered cash rewards, but that didn't improve their blood pressure.

News

MFN model for Medicaid revealed by CMS

The Trump administration has released details of a most-favoured nation (MFN) drug pricing programme for medicines provided by Medicaid.

News

Pfizer, Metsera $10bn marriage back on after rough patch

Pfizer has won the battle for obesity drug developer Metsera, after rival Novo Nordisk said that it would not increase its bid above $10bn.

News

Intellia shares fall after hospitalised CRISPR patient dies

Shares in gene-editing specialist Intellia Therapeutics came under renewed pressure today after a patient in one of its clinical trials died.

News

Braveheart, AAVantgarde rounds head recent biofinancings

Our latest crop of biotech financings has nine-figure rounds for Braveheart and AAVantgarde, with Azalea Therapeutics and NEOK Bio also raising funds.

News

Eisai settles Lenvima patent dispute with Torrent Pharma

A settlement between Eisai and Torrent Pharma will keep a generic version of blockbuster cancer drug Lenvima off the US market until 2030.

AHA: Cash for drug adherence study has disappointing result

MFN model for Medicaid revealed by CMS

Pfizer, Metsera $10bn marriage back on after rough patch

Intellia shares fall after hospitalised CRISPR patient dies

Braveheart, AAVantgarde rounds head recent biofinancings

Eisai settles Lenvima patent dispute with Torrent Pharma

EU clears first drug therapy for rare disease cALD

Discover a new era of healthcare panel engagement: Grounded ...

pharma news

Editor's Picks